These MR-TF modules were clearly represented with the NEPC module MR-TFs enriched in DKO-L2 (vehicle treated), and the transition and adenocarcinoma module MR-TFs enriched in DKO-L2.1 and DKO-L1 subgroups respectively. Here, TF is linked to adenocarcinoma.